Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.
Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.
Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.
Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.
Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.
Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.
Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.
Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.
Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.
Dr Marwan Bukhari and lead author Dr Sarah Mackie (Leeds, UK) discuss the new British Society for Rheumatology giant cell arteritis guideline. The guideline is the Editor’s Choice paper for March 2020.
Dr Mrinalini Dey and Dr Steven Zhao (Liverpool, UK) discuss the association between comorbidities and disease activity in patients with axial spondyloarthritis, using data from the BSRBR-AS.